Kamran Ahrar
0000-0002-7800-2300
1 paper found
Refreshing results…
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy
Missing publications? Search for publications with a matching author name.